RICHMOND, Va.--(BUSINESS WIRE)--April 28, 2004--Outdistancing competitive approaches to predictive modeling within the disease management (DM) industry, Health Management Corporation (HMC) today announced the launch of the next generation of AccuStratSM, which recently completed a successful six-month test period for selected health plan clients.
AccuStrat predicts which members are at highest risk for costly events and exacerbations of the chronic conditions addressed by HMC (asthma, CAD, CHF, COPD, diabetes). According to Michael Cousins, Ph.D., HMC’s executive director of health informatics, AccuStrat identifies those who will most benefit from HMC’s Individualized Intervention PlanSM (IIP) model, an advanced approach, which focuses the most appropriate level and timely delivery of evidence-based interventions necessary for the successful and cost-effective management of the condition.
“In contrast to most predictive models which simply identify high-cost, high-risk members, AccuStrat predicts which members will be the most ‘impactable’,” he explains. “This is significant because the best predictive model in the world is limited if the members it identifies are not manageable through the program. It is believed that HMC is the only DM company offering this capability.”
Dr. Cousins says another distinct AccuStrat advantage over competing statistically based models is its medical management focus, which “looks at how the statistical is married to the clinical.” HMC’s powerful predictive modeling tool incorporates clinical alert algorithms and diagnosis risk scores, and uses artificial intelligence technology to simultaneously examine multiple claims events plus clinical, pharmaceutical, laboratory, and demographic data.
“AccuStrat models are developed specifically for interventions such as disease management and case management,” says Dr. Cousins. “Some companies, in contrast, use models developed for the financial and pricing applications of actuaries and underwriters.”
Dr. Cousins adds that AccuStrat’s rigorous condition-specific stratification models are customized to the client’s unique demographic distribution, regional coding practices, clinical conditions, claims patterns and other factors. This strategy can yield tangible benefits for all parties through HMC’s award-winning DM program.
“With AccuStrat, HMC has the proven tool that finds those members it can impact,” he says. “This translates into a better quality of life for program participants and better control of health care costs for clients.”
ABOUT HMC
Covering approximately 5 million lives throughout America, HMC (www.choosehmc.com) achieves demonstrable value by addressing costly, high impact conditions including asthma, diabetes, CAD, CHF, COPD and high-risk pregnancy for national health plans, employers and government entities. HMC’s URAC-accredited 24-hour Nurse Line also helps control client expenses by encouraging more appropriate, cost-effective use of health care resources. HMC’s ability to demonstrate outstanding program outcomes was a major factor toward its consecutive citations as one of the Top Disease Management Companies in America (SOURCE: Health Industries Research Companies).
Contacts
Media:
Jaime Boyce, 201-641-1911, x 18 jboyce@cpronline.com or
Marketing Communications Manager Jenny Graves, 804-678-0131 jgraves@choosehmc.com